Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

A research team at The University of Osaka revealed that the loss of heterochromatin can cause a chain reaction leading to ...

Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of ...

CSIC, reveals how the bacterium that causes cholera activates its virulence programme, uncovering a single amino acid as a ...

Accomplished RNA therapeutics leader with track record of advancing novel genetic medicines from discovery to FDA approval to ...

When scientists sliced into a block of Siberian permafrost and pulled out a woolly mammoth nicknamed Yuka, they expected to ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Molecular mechanism uncovered in mice by UC Santa Cruz researchers reveals how a father’s diet, stress, and other ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...